Novavax

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Novavax 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. 

CEO
John C.s Jacobs
CEOJohn C.s Jacobs
Employees
749
Employees749
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1987
Founded1987
Employees
749
Employees749

NVAX Key Statistics

Market cap
2.09B
Market cap2.09B
Price-Earnings ratio
-8.30
Price-Earnings ratio-8.30
Dividend yield
—
Dividend yield—
Average volume
11.44M
Average volume11.44M
High today
$13.34
High today$13.34
Low today
$12.40
Low today$12.40
Open price
$12.69
Open price$12.69
Volume
8.55M
Volume8.55M
52 Week high
$13.39
52 Week high$13.39
52 Week low
$6.20
52 Week low$6.20

Stock Snapshot

The current Novavax(NVAX) stock price is $12.40, with a market capitalization of 2.09B. The stock trades at a price-to-earnings (P/E) ratio of -8.30.

As of 2026-10-15, Novavax(NVAX) stock has fluctuated between $12.40 and $13.34. The current price stands at $12.40, placing the stock 0.0% above today's low and -7.0% off the high.

The Novavax(NVAX)'s current trading volume is 8.55M, compared to an average daily volume of 11.44M.

During the past year, Novavax(NVAX) stock moved between $6.20 at its lowest and $13.39 at its peak.

During the past year, Novavax(NVAX) stock moved between $6.20 at its lowest and $13.39 at its peak.

NVAX News

MarketWatch 1d
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch

...

Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Simply Wall St 5d
Novavax Could Be 82% Overvalued On Plague Headlines And Pfizer Deal Focus

Novavax (NVAX) has been back in focus after headlines around a suspected pneumonic plague case and follow up comments from the World Health Organization trigger...

Novavax Could Be 82% Overvalued On Plague Headlines And Pfizer Deal Focus
Benzinga 5d
A New War on Cancer? NIH's Vaccine Initiative Sparks Biotech Stock Rally

A nationwide initiative to accelerate personalized cancer vaccine development is drawing fresh investor interest in vaccine makers, sending several biotechnolog...

A New War on Cancer? NIH's Vaccine Initiative Sparks Biotech Stock Rally

Analyst ratings

57%

of 7 ratings
Buy
57.1%
Hold
14.3%
Sell
28.6%

More NVAX News

24/7 Wall St. 6d
Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies

Investing Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies Vaccine and biotechnology names are leading a sharp sector rally, and a smal...

Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies
TipRanks 6d
Novavax price target raised to $8 from $7 at BofA

BofA analyst Alec Stranahan raised the firm’s price target on Novavax (NVAX) to $8 from $7 and keeps an Underperform rating on the shares as part of a Q3 earnin...

Zacks 6d
Novavax, Inc. is Attracting Investor Attention: Here is What You Should Know

Novavax (NVAX Quick QuoteNVAX - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some...

Novavax, Inc. is Attracting Investor Attention: Here is What You Should Know
Simply Wall St 7d
Should Updated COVID Vaccine Approvals Require Action From Novavax Stock Investors?

Novavax has seen sharp swings in recent days as vaccine stocks reacted to reports of a suspected plague case in Russia, followed by updated COVID-19 vaccine app...

Should Updated COVID Vaccine Approvals Require Action From Novavax Stock Investors?

People also own

Based on the portfolios of people who own NVAX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.